Upon administration of shichimotsukokato (SCMKT), a representative Kampo formula created in Japan, there was a marked reduction in the proteinuria and an improvement in the serum albumin concentration, leading to remission of the nephrotic syndrome and enabling tapering of the renin-angiotensin system inhibitor and diuretics. This evidence concerns the gene ALB and nephrotic syndrome.